These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31311543)

  • 1. The uncertainty with using risk prediction models for individual decision making: an exemplar cohort study examining the prediction of cardiovascular disease in English primary care.
    Pate A; Emsley R; Ashcroft DM; Brown B; van Staa T
    BMC Med; 2019 Jul; 17(1):134. PubMed ID: 31311543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England.
    Pate A; van Staa T; Emsley R
    BMC Med Res Methodol; 2020 Nov; 20(1):289. PubMed ID: 33256644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
    Guthrie B; Rogers G; Livingstone S; Morales DR; Donnan P; Davis S; Youn JH; Hainsworth R; Thompson A; Payne K
    Health Soc Care Deliv Res; 2024 Feb; 12(4):1-275. PubMed ID: 38420962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study of how clinicians use cardiovascular risk assessment to inform statin prescribing decisions.
    Robinson T; Jackson R; Wells S; Kerr A; Marshall R
    N Z Med J; 2017 Oct; 130(1463):28-38. PubMed ID: 28981492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment.
    Xu Z; Arnold M; Stevens D; Kaptoge S; Pennells L; Sweeting MJ; Barrett J; Di Angelantonio E; Wood AM
    Am J Epidemiol; 2021 Oct; 190(10):2000-2014. PubMed ID: 33595074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar.
    Li Y; Sperrin M; Ashcroft DM; van Staa TP
    BMJ; 2020 Nov; 371():m3919. PubMed ID: 33148619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
    van Staa TP; Smeeth L; Ng ES; Goldacre B; Gulliford M
    Heart; 2013 Nov; 99(21):1597-602. PubMed ID: 23735939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the impact of data quality and completeness of electronic health records on predictions of patients' risks of cardiovascular disease.
    Li Y; Sperrin M; Martin GP; Ashcroft DM; van Staa TP
    Int J Med Inform; 2020 Jan; 133():104033. PubMed ID: 31785526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
    BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care.
    Pate A; Emsley R; van Staa T
    Br J Gen Pract; 2020 Nov; 70(700):e765-e771. PubMed ID: 33020170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of acute respiratory infection and acute cardiovascular events following acute respiratory infection among adults with increased cardiovascular risk in England between 2008 and 2018: a retrospective, population-based cohort study.
    Davidson JA; Banerjee A; Smeeth L; McDonald HI; Grint D; Herrett E; Forbes H; Pebody R; Warren-Gash C
    Lancet Digit Health; 2021 Dec; 3(12):e773-e783. PubMed ID: 34823706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
    Collins GS; Altman DG
    BMJ; 2009 Jul; 339():b2584. PubMed ID: 19584409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?
    Li Y; Sperrin M; Belmonte M; Pate A; Ashcroft DM; van Staa TP
    Sci Rep; 2019 Aug; 9(1):11222. PubMed ID: 31375726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods.
    Dong W; Wan EYF; Fong DYT; Tan KC; Tsui WW; Hui EM; Chan KH; Fung CSC; Lam CLK
    Diabetes Obes Metab; 2024 Sep; 26(9):3969-3987. PubMed ID: 39010291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 18. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
    BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses.
    Garg N; Muduli SK; Kapoor A; Tewari S; Kumar S; Khanna R; Goel PK
    Indian Heart J; 2017; 69(4):458-463. PubMed ID: 28822511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.